All R&D articles – Page 4
-
Business
Pfizer teams up with GSK in cancer drug trial
Two companies will collaborate to develop a combination therapy for melanoma
-
Business
DuPont expands Chinese site
Chemical firm’s Shanghai based R&D centre will grow by 17,500 square metres and house 150 more researchers
-
Business
GSK forms Brazilian sustainable chemistry venture
Agreement with research organisation will launch centre for greener, cleaner drug production
-
BusinessGSK to apply for malaria vaccine approval
Infection protection drops over time, but the firm will go ahead with regulatory submission
-
Business
Nanobody inflammation drug attracts Abbvie
$840m licensing deal shows support for antibody fragments
-
BusinessTwo way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
BusinessGas specialist branches out into carbon nanotubes
Linde group launches ink made with long, individual tubes
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
Business
Russian investment vehicle sets sights on innovative drugs
Rusnano hopes to make a killing by investing in new technologies in the pharmaceutical sector
-
Business
AstraZeneca partners with Moderna for $240 million
Pharma company sheds more jobs and backs messenger RNA therapeutics
-
Business
Return on drug R&D dropping
The pharma industry is getting less and less return on investment in R&D but trend seems to be bottoming out
-
Business
Drug R&D costs rising
Review from UK consultancy suggests ten-fold increase in per medicine R&D costs over last 30 years
-
BusinessWhat lies within
Bayer boss Marijn Dekkers aims to increase impact of good R&D across different internal units
-
Business
Bayer and Evotec team up on endometriosis
German collaboration aims to develop three drug candidates in five years
-
Business
Dow tax case raises R&D questions
US court blocks Dow attempt to recoup costs under the R&D tax credit scheme